Found: 6
Select item for more details and to access through your institution.
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49286-x
- By:
- Publication type:
- Article
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1279387
- By:
- Publication type:
- Article
Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 640, p. 1, doi. 10.1126/scitranslmed.abn2231
- By:
- Publication type:
- Article
Inhibition of the phosphoinositide 3-kinase-AKT-cyclic GMP-c-Jun N-terminal kinase signaling pathway attenuates the development of morphine tolerance in a mouse model of neuropathic pain.
- Published in:
- Molecular Pain, 2021, p. 1, doi. 10.1177/17448069211003375
- By:
- Publication type:
- Article
Inhibition of the phosphoinositide 3-kinase-AKT-cyclic GMP-c-Jun N-terminal kinase signaling pathway attenuates the development of morphine tolerance in a mouse model of neuropathic pain.
- Published in:
- Molecular Pain, 2021, p. 1, doi. 10.1177/17448069211003375
- By:
- Publication type:
- Article
Morphine Efficacy, Tolerance, and Hypersensitivity Are Altered After Modulation of SUR1 Subtype K<sub>ATP</sub> Channel Activity in Mice.
- Published in:
- Frontiers in Neuroscience, 2019, v. 13, p. 1, doi. 10.3389/fnins.2019.01122
- By:
- Publication type:
- Article